Trial
NCT02571530
Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
—
Condition
Neoplasm Metastasis
Intervention
Intra-arterial Cerebral Infusion of Trastuzumab
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-03